France
- Resistance Data
- Use Data
Data includes aggregated resistance rates for isolates (includes intermediate resistance) from blood and cerebrospinal fluid (i.e., invasive) from inpatients of all ages. Because of differences in scope of collections and testing methods, caution should be exercised in comparing across countries. For more details see methodology.
Country boundaries/designations do not represent CDDEP opinion concerning the legal status of any country, territory, city, or area of its authorities, or concerning the delimitation of its frontiers or boundaries.
Pathogens:
Acinetobacter baumannii
Enterobacter aerogenes/cloacae
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella pneumoniae
Pseudomonas aeruginosa
Salmonella Paratyphi
Salmonella Typhi
Staphylococcus aureus
Streptococcus pneumoniae
Antibiotics
Amikacin
Aminoglycosides
Aminoglycosides (high-level)
Aminopenicillins
Amoxicillin-clavulanate
Ampicillin-sulbactam
Carbapenems
Ceftazidime
Cephalosporins (3rd gen)
Fluoroquinolones
Glycylcyclines
Linezolid
Macrolides
Oxacillin (MRSA)
Penicillins
Piperacillin-tazobactam
Polymyxins
Rifampicin
Tetracyclines
Trimethoprim-sulfamethoxazole
Vancomycin
Sources
To learn how this data was collected, see our methodology overview.
Boundaries and names shown and the designation used on these maps do not imply the expression of any opinion whatsoever on the part of CDDEP concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries.
Comments? Click here to let us know what you think of ResistanceMap
